Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Elena Vega

Adding Vasopressin Earlier Did Not Improve Septic Shock Survival in 3,959-Patient Trial at 13 Utah and Idaho Hospitals

Starting the blood pressure drug vasopressin earlier did not improve survival, shorten hospital stays, or speed recovery for adults with septic shock, compared with waiting until their condition worsened, according to a trial published online in JAMA on October 14. The study enrolled 3,959 adults at 13 Intermountain Health hospitals in Utah and Idaho.

The question comes up often in intensive care units (ICUs). Some critical care teams add vasopressin soon after a patient needs a blood pressure drug, while others wait until the patient needs higher doses of the first drug.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.